Recently, according to foreign media reports, a medical company in the United States has developed a new drug or cure AIDS (HIV), which has been submitted to the U.S. Food and Drug Administration (FDA) for approval.
According to the report,AGT, the US gene technology company, recently announced that it has developed agt103-t, a drug that is expected to cure AIDS, and has submitted a clinical trial application to the US Food and Drug Administration。
The new drug is dedicated to repair the key immune system damage caused by AIDS and repair the defects of auxiliary T cells,And provide persistent virus control. With the approval of FDA, phase 1 clinical trial can be carried out.
The ultimate goal of the treatment is to restore the natural immunity of the human body to AIDS,So that the body's immune system will treat it like any other disease。
To date, about 37.9 million people around the world have been infected with HIV; in 2018, 1.7 million new HIV infections worldwide. Due to the development and global distribution of antiretroviral drugs, the devastating impact of HIV / AIDS has been greatly reduced. However, there is still a lack of effective drugs to eradicate AIDS infection worldwide.
Jeff Galvin, chief executive of AGT, said that if the test is successful,Patients will be free from the side effects of existing drugs, and HIV will not develop into AIDS。